Loading clinical trials...
Loading clinical trials...
A Double Blind, Crossover Study to Evaluate Safety and Efficacy of an Adaptive Deep Brain Stimulation Closed-loop Method Compared With Conventional Deep Brain Stimulation in Patients With Parkinson's Disease
This is an exploratory study to preliminary assess safety and efficacy of an adaptive Deep Brain Stimulation (DBS) closed-loop method in patients with PD. The study has been designed as a double blind randomized crossover trial that uses conventional DBS as a concurrent control in PD patients in need of Implantable Pulse Generator (IPG) replacement.
PD patients in need of IPG replacement will be screened to identify the ones eligible for enrollment. Randomized patients will undergo 2 days of experimental sessions (i.e. one per each type of stimulation mode, cDBS and aDBS), in a well-controlled environment (i.e. during hospitalization). During each experimental session experienced neurologists will collect information on safety and efficacy endpoints.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Centro Parkinson e Disturbi del Movimento ASST G.Pini- CTO
Milan, Italy
Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico
Milan, Italy
IRCCS Istituto Ortopedico Galeazzi
Milan, Italy
Fondazione Istituto Neurologico Nazionale Casimiro Mondino
Pavia, Italy
Start Date
June 1, 2017
Primary Completion Date
December 30, 2018
Completion Date
December 30, 2018
Last Updated
November 19, 2020
6
ACTUAL participants
adaptive Deep Brain Stimulation
DEVICE
conventional Deep Brain Stimulation
DEVICE
Lead Sponsor
Newronika
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06113640